Table 1.
Study and participant characteristics.
| Study (Author, Year) |
Group | Study Characteristics | Participant Characteristics | |
|---|---|---|---|---|
| Country; Study Design; Journal |
Sample Size; Male Percentage; Age |
CVD Diagnosis; Risk Factors or Comorbidities |
||
| Cacau et al. [38] (2013) |
EG | Brazil; RCT; Rev Bras Cir Cardiovasc |
30; 43.0%; 49.2 ± 2.6 years | CAD; NR |
| CG | 30; 53.0%; 52.0 ± 2.4 years | |||
| Chuang et al. [39] (2006) |
EG | Taiwan; RCT; Phys Ther |
10; 100%; 65.7 ± 14.5 years | CAD; AHT, DM2, DLP, SM |
| CG | 10; 100%; 63.7 ± 10.3 years | |||
| Garcia-Bravo et al. [42] (2020) |
EG | Spain; RCT; Int J Environ Res Public Health |
10; 70.0%; 48.7 ± 6.7 years | CAD; NR |
| CG | 10; 100%; 53.7 ± 10.3 years | |||
| Gulick et al. [28] (2021) |
EG | USA; RCT; J Med Internet Res |
41; 72.0% *; 61 ± 9.9 years * | MS; COPD |
| CG | 31; 72.0% *; 61 ± 9.9 years * | |||
| Jaarsma et al. [29] (2021) |
EG | Sweden, Italy, Israel, Netherlands, Germany, USA; RCT; Eur J Heart Fail |
234; 72.0% ^; 66 ± 12.0 years | CHF; AHT, AF, CVA, COPD, DM2, MI |
| CG | 230; 70.0% ^; 67 ± 11.0 years | |||
| Klompstra et al. [40] (2014) |
EG | Sweden; Single Intervention; BMC Geriatrics |
32; 68.8%; 63.0 ± 14.0 years | CHF; SM |
| Ruivo et al. [24] (2017) |
EG | Ireland; RCT; J Cardiopulm Rehabil Prev |
16; 87.5%; 59.4 ± 11.8 years | MS; AHT, DLP; DM2, OB, SM |
| CG | 16; 75.0%; 60.4 ± 8.5 years | |||
| Vieira et al. [41] (2018) |
EG | Portugal; RCT; Disabil Rehabil: Assist Technol |
11; 100%; 55.0 ± 9.0 years | CAD; AHT, DLP; DM2, OB, SM |
| CG1 | 11; 100%; 59.0 ± 11.3 years | |||
| CG2 | 11; 100%; 59.0 ± 5.8 years | |||
AHT, arterial hypertension; AF, atrial fibrillation; CAD, coronary artery disease; CG, control group; CHF, chronic heart failure; COPD, chronic obstructive pulmonary disease; CVA, cerebrovascular accident; DLP, dyslipidemia; DM2, diabetes mellitus 2; EG, experimental group; MI, myocardial infarction; MS, mixed sample; NR, no reported; RCT, randomized controlled trial; SM, smoking; OB, obesity; *, data not disaggregated by groups; ^, data reported in the pretreatment measure. Values are reported as mean ± standard deviation unless otherwise is stated.